|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector. |
| 公司地址
| 21925 West Field Parkway, Suite 235, Deer Park, IL, USA, 60010-7278 |
| 電話號碼
| +1 847 787-7361 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.etonpharma.com |
| 員工數量
| 44 |
| Mr. David C. Krempa |
Chief Business Officer |
美元 460.46K |
24/04/2026 |
| Mr. Sean E. Brynjelsen |
President, Chief Executive Officer and Director |
美元 712.43K |
24/04/2026 |
| Ms. Judith Matthews |
Executive Vice President, Accounting and Finance |
-- |
16/04/2026 |
| Mr. James R. Gruber |
Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary |
美元 460.46K |
16/04/2026 |
| Ms. Ipek Erdogan-Trinkaus |
Chief Commercial Officer |
美元 402.72K |
24/04/2026 |
|
|
| Mr. Paul Victor Maier |
Independent Director |
24/04/2026 |
| Dr. Norbert G. Riedel,PhD |
Chairman of the Board |
24/04/2026 |
| Ms. Jennifer McKie Adams |
Independent Director |
24/04/2026 |
| Mr. Sean E. Brynjelsen |
President, Chief Executive Officer and Director |
24/04/2026 |
| Mr. Charles J. Casamento |
Independent Director |
24/04/2026 |
|
|
|
|
